Inotrem is a startup based in France, most recent round Series-c-plus, 1 tracked investor.
Based in France, Inotrem is a startup founded in 2014. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
Inotrem is a clinical-stage biotechnology company developing first-in-class immunotherapies. They focus on modulating the TREM-1 pathway to treat acute and chronic inflammatory diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.